DexCom's high P/S ratio is justified by its superior revenue...
DexCom's high P/S ratio is justified by its superior revenue growth and future prospects. Investors' confidence in the company's future revenues is reflected in this ratio, suggesting the share price won't fall significantly soon.
DexCom, Inc.'s (NASDAQ:DXCM) P/S Still Appears To Be Reasonable
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment